AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $19,775,901 | +72.9% | 256,397 | 0.0% | 0.01% | +66.7% |
| Q3 2022 | $11,440,434 | +28.2% | 256,397 | +10.0% | 0.00% | +50.0% |
| Q2 2022 | $8,925,662 | +21.6% | 233,046 | +31.5% | 0.00% | 0.0% |
| Q1 2022 | $7,337,619 | +1.0% | 177,280 | -7.8% | 0.00% | +100.0% |
| Q4 2021 | $7,266,000 | +14.6% | 192,329 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $6,339,000 | +51.0% | 192,329 | +209.1% | 0.00% | 0.0% |
| Q2 2021 | $4,198,000 | -64.3% | 62,223 | -70.1% | 0.00% | -66.7% |
| Q1 2021 | $11,773,000 | -47.4% | 207,922 | -24.4% | 0.00% | -40.0% |
| Q4 2020 | $22,397,000 | +10.7% | 274,909 | -3.2% | 0.01% | 0.0% |
| Q3 2020 | $20,225,000 | -39.5% | 283,855 | -30.1% | 0.01% | -50.0% |
| Q2 2020 | $33,422,000 | +84.2% | 406,198 | +31.7% | 0.01% | +66.7% |
| Q1 2020 | $18,143,000 | – | 308,392 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
| Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
| WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
| RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
| MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
| RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
| Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
| ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
| Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |